Re: Two big thank you’s
|
2
|
Zenith Epigenetics
|
Nov 24, 2022 07:53PM
|
Re: Two big thank you’s
|
5
|
Zenith Epigenetics
|
Nov 24, 2022 05:54PM
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
4
|
Resverlogix Corp.
|
Nov 14, 2022 05:46PM
|
Re: find it interesting that RVXCF.....
|
6
|
Resverlogix Corp.
|
Nov 11, 2022 12:24PM
|
Re: USA ZHCLF investors
|
5
|
Zenith Epigenetics
|
Nov 02, 2022 10:18PM
|
Re: Toxicity
|
3
|
Zenith Epigenetics
|
Nov 02, 2022 04:19PM
|
Re: Toxicity
|
4
|
Zenith Epigenetics
|
Nov 02, 2022 03:46PM
|
Re: USA ZHCLF investors
|
4
|
Zenith Epigenetics
|
Nov 02, 2022 03:33PM
|
Re: USA ZHCLF investors
|
3
|
Zenith Epigenetics
|
Nov 01, 2022 07:26PM
|
Re: USA ZHCLF investors
|
5
|
Zenith Epigenetics
|
Nov 01, 2022 05:15PM
|
Re: USA ZHCLF investors
|
4
|
Zenith Epigenetics
|
Nov 01, 2022 04:24PM
|
Re: USA ZHCLF investors
|
2
|
Zenith Epigenetics
|
Oct 30, 2022 05:01PM
|
Re: USA ZHCLF investors
|
2
|
Zenith Epigenetics
|
Oct 30, 2022 04:07PM
|
Re: USA ZHCLF investors
|
3
|
Zenith Epigenetics
|
Oct 30, 2022 01:28PM
|
Re: USA ZHCLF investors
|
5
|
Zenith Epigenetics
|
Oct 29, 2022 03:45PM
|
Re: from IR "Hepalink does not own Zenith shares."
|
3
|
Zenith Epigenetics
|
Oct 26, 2022 05:10PM
|
Re: Anyone expecting anything prior to or at the AGM
|
4
|
Zenith Epigenetics
|
Oct 05, 2022 09:11PM
|
Re: Latest on COVID-19
|
8
|
Resverlogix Corp.
|
Sep 28, 2022 01:41PM
|
Re: Trading
|
4
|
Zenith Epigenetics
|
Sep 21, 2022 12:02PM
|
Re: Looking forward now , can/will management use this meeting as the start of many positive updates?
|
2
|
Resverlogix Corp.
|
Aug 24, 2022 03:10PM
|